Transmigration of breast cancer and melanoma cells through the blood-brain barrier similarities and differences /

Brain metastases are common and devastating complications of both breast cancer and melanoma. Although mammary carcinoma brain metastases are more frequent than those originating from melanoma, this latter has the highest tropism to the brain. Using static and dynamic in vitro approaches, here we sh...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerző: Molnár Judit
További közreműködők: Krizbai István (Témavezető)
Wilhelm Imola (Témavezető)
Dokumentumtípus: Disszertáció
Megjelent: 2016-05-17
Tárgyszavak:
doi:10.14232/phd.2967

mtmt:3105146
Online Access:http://doktori.ek.szte.hu/2967
LEADER 02635nta a2200265 i 4500
001 dokt2967
005 20200504125534.0
008 160506s2016 hu om 0|| eng d
024 7 |a 10.14232/phd.2967  |2 doi 
024 7 |a 3105146  |2 mtmt 
040 |a SZTE Doktori Repozitórium  |b hun 
041 |a eng 
100 1 |a Molnár Judit 
245 1 0 |a Transmigration of breast cancer and melanoma cells through the blood-brain barrier  |h [elektronikus dokumentum] :  |b similarities and differences /  |c  Molnár Judit 
246 1 0 |a Az emlőkarcinóma és melanóma sejtek átvándorlása a vér-agy gáton keresztül: hasonlóságok és különbségek  |h [elektronikus dokumentum] 
260 |c 2016-05-17 
502 |a Disszertacio 
520 3 |a Brain metastases are common and devastating complications of both breast cancer and melanoma. Although mammary carcinoma brain metastases are more frequent than those originating from melanoma, this latter has the highest tropism to the brain. Using static and dynamic in vitro approaches, here we show that melanoma cells have increased adhesion to the brain endothelium in comparison to breast cancer cells. Moreover, melanoma cells can transmigrate more rapidly and in a higher number through brain endothelial monolayers than breast cancer cells. In addition, melanoma cells have increased ability to impair tight junctions of cerebral endothelial cells. We also show that inhibition of Rac or PI3K impedes adhesion of breast cancer cells and melanoma cells to the brain endothelium. In addition, inhibition of Rac or PI3K inhibits the late phase of transmigration of breast cancer cells and the early phase of transmigration of melanoma cells. On the other hand, the Rac inhibitor EHT1864 impairs the junctional integrity of the brain endothelium, while the PI3K inhibitor LY294002 has no damaging effect on interendothelial junctions. We suggest that targeting the PI3K/Akt pathway may represent a novel opportunity in preventing the formation of brain metastases of melanoma and breast cancer. 
650 4 |a elméleti orvostudományok 
650 4 |a Általános orvostudomány 
700 0 1 |a Krizbai István  |e ths 
700 0 1 |a Wilhelm Imola  |e ths 
856 4 0 |u https://doktori.bibl.u-szeged.hu/id/eprint/2967/1/2016_Judit%20Moln%C3%A1r_PhD%20thesis_final.pdf  |z Dokumentum-elérés  
856 4 0 |u https://doktori.bibl.u-szeged.hu/id/eprint/2967/8/2016%2003%2003_angol%20nyelv%C5%B1%20%C3%B6sszefoglal%C3%B3_v%C3%A9gleges.pdf  |z Dokumentum-elérés  
856 4 0 |u https://doktori.bibl.u-szeged.hu/id/eprint/2967/7/2016%2003%2003_magyar%20nyelv%C5%B1%20%C3%B6sszefoglal%C3%B3_v%C3%A9gleges.pdf  |z Dokumentum-elérés